PT Trimegah Bangun Persada Tbk
IDX:NCKL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
560
1 360
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
PT Trimegah Bangun Persada Tbk
| Current Assets | 12.3T |
| Cash & Short-Term Investments | 5T |
| Receivables | 1.9T |
| Other Current Assets | 5.5T |
| Non-Current Assets | 46.2T |
| Long-Term Investments | 23T |
| PP&E | 22.8T |
| Other Non-Current Assets | 302.6B |
| Current Liabilities | 6.3T |
| Accounts Payable | 1.5T |
| Accrued Liabilities | 145B |
| Short-Term Debt | 500.4B |
| Other Current Liabilities | 4.2T |
| Non-Current Liabilities | 16.5T |
| Long-Term Debt | 8T |
| Other Non-Current Liabilities | 8.5T |
Balance Sheet
PT Trimegah Bangun Persada Tbk
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
1 896 428
|
0
|
0
|
0
|
3 934 723
|
6 486 402
|
|
| Cash |
1 896 428
|
0
|
0
|
0
|
3 934 723
|
6 486 402
|
|
| Short-Term Investments |
25 000
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
279 815
|
284 936
|
473 453
|
449 140
|
1 342 818
|
1 574 124
|
|
| Accounts Receivables |
59 948
|
0
|
148 811
|
181 406
|
1 242 804
|
1 541 484
|
|
| Other Receivables |
219 867
|
284 936
|
324 642
|
267 734
|
100 014
|
32 640
|
|
| Inventory |
853 773
|
1 069 151
|
1 299 803
|
4 087 247
|
5 503 560
|
5 158 144
|
|
| Other Current Assets |
311 822
|
677 197
|
420 953
|
520 701
|
978 267
|
245 893
|
|
| Total Current Assets |
3 366 839
|
4 023 958
|
4 772 065
|
6 333 948
|
11 759 368
|
13 464 563
|
|
| PP&E Net |
7 756 004
|
14 665 952
|
11 027 046
|
20 724 996
|
22 585 937
|
22 947 460
|
|
| PP&E Gross |
7 756 004
|
14 665 952
|
11 027 046
|
20 724 996
|
22 585 937
|
22 947 460
|
|
| Accumulated Depreciation |
1 303 127
|
1 772 891
|
2 174 892
|
2 872 696
|
3 956 126
|
5 864 817
|
|
| Note Receivable |
120 718
|
65 379
|
45 693
|
17 567
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
3 552 604
|
6 989 605
|
10 705 329
|
15 520 930
|
|
| Other Long-Term Assets |
2 069 273
|
1 504 975
|
1 604 451
|
538 580
|
238 392
|
320 885
|
|
| Total Assets |
13 312 834
N/A
|
20 260 264
+52%
|
21 001 860
+4%
|
34 604 697
+65%
|
45 289 026
+31%
|
52 253 838
+15%
|
|
| Liabilities | |||||||
| Accounts Payable |
68 044
|
76 030
|
125 114
|
1 209 127
|
1 871 351
|
1 245 792
|
|
| Accrued Liabilities |
57 857
|
64 577
|
59 436
|
130 050
|
223 470
|
263 303
|
|
| Short-Term Debt |
2 434 778
|
4 772 598
|
0
|
0
|
432 142
|
0
|
|
| Current Portion of Long-Term Debt |
615 467
|
664 346
|
4 334 606
|
116 555
|
1 371 126
|
1 678 891
|
|
| Other Current Liabilities |
1 395 637
|
3 107 188
|
4 184 754
|
8 752 969
|
5 408 315
|
2 665 580
|
|
| Total Current Liabilities |
4 571 784
|
8 684 739
|
8 703 910
|
10 208 700
|
9 306 404
|
5 853 566
|
|
| Long-Term Debt |
2 536 081
|
2 786 522
|
2 292 170
|
9 567 308
|
6 781 426
|
9 137 997
|
|
| Deferred Income Tax |
161 848
|
197 389
|
260 843
|
344 762
|
387 607
|
461 987
|
|
| Minority Interest |
2 590 503
|
4 559 334
|
3 900 966
|
4 745 337
|
4 894 651
|
5 967 791
|
|
| Other Liabilities |
75 971
|
111 839
|
202 671
|
254 794
|
421 626
|
346 234
|
|
| Total Liabilities |
9 936 187
N/A
|
16 339 824
+64%
|
15 360 559
-6%
|
25 120 901
+64%
|
21 791 714
-13%
|
21 767 575
0%
|
|
| Equity | |||||||
| Common Stock |
10 100
|
10 100
|
10 100
|
5 510 100
|
6 309 860
|
6 309 860
|
|
| Retained Earnings |
3 064 951
|
3 616 342
|
5 248 687
|
1 617 297
|
6 130 451
|
12 366 021
|
|
| Additional Paid In Capital |
311 250
|
311 250
|
351 666
|
1 470 552
|
10 367 590
|
10 367 571
|
|
| Other Equity |
9 654
|
17 252
|
30 848
|
885 847
|
689 411
|
1 442 811
|
|
| Total Equity |
3 376 647
N/A
|
3 920 440
+16%
|
5 641 301
+44%
|
9 483 796
+68%
|
23 497 312
+148%
|
30 486 263
+30%
|
|
| Total Liabilities & Equity |
13 312 834
N/A
|
20 260 264
+52%
|
21 001 860
+4%
|
34 604 697
+65%
|
45 289 026
+31%
|
52 253 838
+15%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
63 099
|
63 099
|
63 099
|
55 101
|
63 099
|
63 099
|
|